Insight journal - Company

Mitsubishi Tanabe: Partnering activity 2005-2013

Posted on 05 November 2013

Tags: , ,

Mitsubishi Tanabe, a big pharma company based in Japan, announced over 20 partnering / licensing deals since 2005. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology and central nervous system diseases. 

Abstracted from: Partnering Deals and Alliances with Mitsubishi Tanabe

The company having been recently formed in 2007, has had a steady growth and built its way through into the top 50 pharmaceutical companies in the world. On the partnering front, a reasonable amount of partnering deals has been announced with 12 deals signed last year.

The following figure shows the level of Mitsubishi Tanabe partnering deal announcements since 2005.

Figure 1: Mitsubishi Tanabe partnering deals 2005-2013

Figure 1: Mitsubishi Tanabe partnering deals 2005-2013

 

Source: Current Agreements, 2013

Analysis of the partnering deals shows a strong emphasis on partnerships in psychiatry, metabolic and cardiovascular diseases.

The following table provides an overview of the partnering deals announced by Mitsubishi Tanabe based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with Mitsubishi Tanabe

Figure 2: Mitsubishi Tanabe partnering deals by therapy area 2005-2013

Figure 2: Mitsubishi Tanabe partnering deals by therapy area 2005-2013

Source: Current Agreements, 2013

Further analysis of these deals shows that Mitsubishi Tanabe has a preference for licensing deals, collaborative R&D and research similar to many other top pharmaceutical or big pharma companies. Such partnering deals provide the right for Mitsubishi Tanabe to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Mitsubishi Tanabe based on deal type disclosed.

Figure 3: Mitsubishi Tanabe partnering deals by deal type 2005-2013

Figure 3: Mitsubishi Tanabe partnering deals by deal type 2005-2013

Source: Current Agreements, 2013

When looking at stage of development at partnering deal signing, the most popular stage at signing is discovery with 8 deal announcements, followed by marketed stage with 6 deal announcements.

Mitsubishi Tanabe is also active in partnering at preclinical, phase I and phase II stage deals. Such deals are of on-going importance to all top pharmaceutical companies as they seek to bolster their pipeline, fill gaps left as a result of drug candidates failing during clinical development, and ensure they have replacement products for when key drugs come off patent.

The following table provides an overview of the partnering deals announced by Mitsubishi Tanabe based on stage of development at signature.

Figure 4: Mitsubishi Tanabe partnering by stage of development 2005-2013

Figure 4: Mitsubishi Tanabe partnering by stage of development 2005-2013

Source: Current Agreements, 2013

Mitsubishi Tanabe has signed over 20 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Mitsubishi Tanabe partnering deals by headline value 2005-2013

Figure 5: Top Mitsubishi Tanabe partnering deals by headline value 2005-2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Mitsubishi Tanabe

Mitsubishi Tanabe partnering at Current Agreements

View all partnering deals for Mitsubishi Tanabe: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Mitsubishi Tanabe

 

More 

Summary profile data for Mitsubishi Tanabe

Partnering interests for Mitsubishi Tanabe

M&A activity for Mitsubishi Tanabe

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Mitsubishi Tanabe

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

 

Available resources for deal coverage for Mitsubishi Tanabe

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Mitsubishi Tanabe company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply